Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: A modelling study

The Lancet Global Health

Volumn 3, Issue 12, 2015, Pages e746-e757

  Kontis, Vasilis ^a   Mathers, Colin D ^b   Bonita, Ruth ^c   Stevens, Gretchen A ^b   Rehm, Jürgen ^d,e,f   Shield, Kevin D ^d   Riley, Leanne M ^b   Poznyak, Vladimir ^b   Jabbour, Samer ^g   Garg, Renu Madanlal ^h   Hennis, Anselm ⁱ   Fouad, Heba M ^j   Beaglehole, Robert ^c   Ezzati, Majid ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^h WHO Regional Office for South East Asia   (India)

ⁱ PAN AMERICAN HEALTH ORGANIZATION   (United States)

^j WHO Regional Office for the Eastern Mediterranean   (Egypt)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ETHNICITY; FEMALE; GENDER; HYPERGLYCEMIA; HYPERTENSION; MALE; MORTALITY; NON COMMUNICABLE DISEASE; OBESITY; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SALT INTAKE; TOBACCO USE; ADVERSE EFFECTS; BIOLOGICAL MODEL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS; DRINKING BEHAVIOR; GLUCOSE BLOOD LEVEL; HEALTH; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; METABOLISM; MIDDLE AGED; MOTIVATION; NEOPLASMS; PREMATURE MORTALITY; PREVENTION AND CONTROL; RESPIRATORY TRACT DISEASES; SMOKING;

GLUCOSE BLOOD LEVEL; SALT INTAKE;

ADULT; AGED; ALCOHOL DRINKING; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GLOBAL HEALTH; GOALS; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MORTALITY, PREMATURE; NEOPLASMS; OBESITY; RESPIRATORY TRACT DISEASES; RISK FACTORS; SMOKING; SODIUM CHLORIDE, DIETARY;

EID: 84947434854     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(15)00179-5     Document Type: Article

References (38)

1. Global action plan for the prevention and control of noncommunicable diseases 2013-2020 2013, WHO, World Health Organization, Geneva.
2. Kontis V, Mathers CD, Rehm J, et al. Contribution of six risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. Lancet 2014, 384:427-437.
3. Di Cesare M, Khang YH, Asaria P, et al. Inequalities in non-communicable diseases and effective responses. Lancet 2013, 381:585-597.
4. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014, 2:634-647. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration.
5. Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet 2011, 377:568-577.
6. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011, 378:31-40.
7. Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet 2011, 377:578-586.
8. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011, 377:557-567.
9. Ezzati M, Riboli E Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med 2013, 369:954-964.
10. Gmel G, Labhart F, Shield KD, Rylett M, Lachenmeier DW, Rehm J A global overview of alcohol consumpiton patterns. Alcohol: science, policy and public health 2013, 115-124. Oxford University Press, Oxford. P. Boyle, P. Boffetta, A.B. Lowenfels (Eds.).
11. Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol 2015, 12:508-530.
12. Di Cesare M, Bennett JE, Best N, Stevens GA, Danaei G, Ezzati M The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries. Int J Epidemiol 2013, 42:838-848.
13. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000, 355:675-687.
14. Oza S, Thun MJ, Henley SJ, Lopez AD, Ezzati M How many deaths are attributable to smoking in the United States? Comparison of methods for estimating smoking-attributable mortality when smoking prevalence changes. Prev Med 2011, 52:428-433.
15. Doll R, Peto R, Boreham J, Sutherland I Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004, 328:1519.
16. Law MR, Wald NJ, Thompson SG By How much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ 1994, 308:367-373.
17. Holmes J, Meier PS, Booth A, Guo Y, Brennan A The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses. Drug Alcohol Depend 2012, 123:7-14.
18. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet 2008, 372:1473-1483.
19. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003, 362:271-280.
20. Lu Y, Hajifathalian K, Ezzati M, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014, 383:970-983. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration.
21. He FJ, Li J, Macgregor GA Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346:f1325.
22. Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007, World Cancer Research Fund/American Institute for Cancer Research, AICR, Washington, DC.
23. Bilano V, Gilmour S, Moffiet T, et al. Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet 2015, 385:966-976.
24. Mathers CD, Loncar D Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
25. Booth H, Tickle L Mortality modelling and forecasting: a review of methods. Ann Actuarial Sci 2008, 3:3-43.
26. Bennett JE, Li G, Foreman K, et al. The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting. Lancet 2015, 386:163-170.
27. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260.
28. Wild CP, Bray F, Forman D, Franceschi S, Sankaranarayanan R, Straif K Cancer in the 25 × 25 non-communicable disease targets. Lancet 2014, 384:1502-1503.
29. Ezzati M, Riboli E Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science 2012, 337:1482-1487.
30. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007, 370:2044-2053.
31. Farzadfar F, Murray CJ, Gakidou E, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet 2012, 379:47-54.
32. Hogerzeil HV, Liberman J, Wirtz VJ, et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet 2013, 381:680-689.
33. Hajifathalian K, Ueda P, Lu Y, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol 2015, 3:339-355.
34. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings WHO, (accessed May 18, 2015). http://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf.
35. Karthikeyan G, Mayosi BM Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?. Circulation 2009, 120:709-713.
36. Follow-up to the outcome of the Millennium Summit NCD Alliance, (accessed May 18, 2015). http://ncdalliance.org/sites/default/files/rfiles/UN%20Review%20Outcome%20Document%20-%20Adopted.pdf.
37. Beaglehole R, Bonita R, Ezzati M, et al. NCD Countdown 2025: accountability for the 25 × 25 NCD mortality reduction target. Lancet 2014, 384:105-107.
38. Bonita R, Magnusson R, Bovet P, et al. Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet 2013, 381:575-584.